Tag: Nathan Emeritz
Ingenia eyes USD42m IPO as first US company listing in Korea
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
Rewarding legal excellence in firms with their main operations outside Delhi and Mumbai
Corporate governance is evolving beyond compliance to encompass accountability, sustainability?and long-term value
Follow us on LinkedIn